While 18 immune cell types showed no good correlation with the analysed tumour stages, the marker enrichment analysis revealed reduced numbers of T cells, CD8+, Th1 as well as CD4+ regulatory T cells and dendritic cells in samples from more advanced HCC patients (Fig. 3B). The gene discussed is CD4; the disease is hepatocellular carcinoma.